分量流量储备引导的延迟冠状动脉再血管化的结果
Mohammad Reza Beyranvand1, Mehdi Sheibani1, Hana Mirzabeigi1
1Department of Cardiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
概括
推迟对中等冠状动脉病变的重血管化,而非缺血的分量流量储备 (FFR) 值是安全的. 这种策略与医疗管理相结合,在中度冠状动脉狭窄症患者中显示出较低的死亡率和再血管化率.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 诊断成像 诊断成像 诊断成像
背景情况:
- 分数流量储备 (FFR) 评估冠状动脉狭窄的意义.
- 0.80或更低的FFR表明需要重新血管化的重大病变.
- 较高的FFR值表明非显著的病变,但推迟再血管化的结果各不相同.
研究的目的:
- 评估中期冠状动脉狭窄症中推迟再血管化的结果.
- 评估非血性FFR值的病变非再血管化的安全性.
主要方法:
- 2013年3月至2017年8月的单中心研究.
- 包括中度 (50%-69%) 冠状动脉狭窄和FFR>0.8.8的患者.
- 随访记录了总死亡率和延迟的损伤再血管化 (DLR).
主要成果:
- 分析了115名患者 (平均年龄为58.35岁,61.7%是男性).
- 平均随访时间为32个月.
- 死亡率为0.8%,其中4.8%接受了再血管化.
结论:
- 推迟对非缺血性FFR的中间冠状动脉病变进行再血管化是一种安全的策略.
- 医疗管理对这些患者是有效的.
- 这种方法与有利的长期结果有关.
相关概念视频
01:27Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
01:30Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2